ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH‐DOSE THERAPY. (12th June 2019)

Record Type:: Journal Article
Title:: ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH‐DOSE THERAPY. (12th June 2019)
Main Title:: ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH‐DOSE THERAPY
Authors:: Davies, A.J.
Tansley Hancock, O.
Cummin, T.
Caddy, J.
Stanton, L.
Burton, C.
Barrans, S.
Coleman, A.
Osborne, W.
McKay, P.
Griffiths, G.
Johnson, P.
Abstract:
Is Part Of:: Hematological oncology. Volume 37(2019)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 37(2019)Supplement 2
Issue Display:: Volume 37, Issue 2 (2019)
Year:: 2019
Volume:: 37
Issue:: 2
Issue Sort Value:: 2019-0037-0002-0000
Page Start:: 555
Page End:: 556
Publication Date:: 2019-06-12
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.1_2632 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 12428.xml